Prometheus Biosciences - Stock Price History | RXDX

Historical daily share price chart and data for Prometheus Biosciences since 2021 adjusted for splits. The latest closing stock price for Prometheus Biosciences as of September 27, 2021 is 26.00.
  • The all-time high Prometheus Biosciences stock closing price was 29.65 on June 16, 2021.
  • The Prometheus Biosciences 52-week high stock price is 30.64, which is 17.8% above the current share price.
  • The Prometheus Biosciences 52-week low stock price is 16.11, which is 38% below the current share price.
  • The average Prometheus Biosciences stock price for the last 52 weeks is 22.71.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Prometheus Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.011B $0.001B
Prometheus Biosciences Inc. is a biotechnology company. It involved in the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease. Prometheus Biosciences Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29